Debu Tripathy, MD
Professor of Medicine & Chair, Breast Medical Oncology, University of Texas MD Anderson Cancer Center
Highlights
- LBBC Medical Advisory Board member since 2023
- Speaker, 2024 Conference on Metastatic Breast Cancer and 2022 Virtual Conference on Metastatic Breast Cancer
- Clinical research focuses on finding new treatments for breast cancer
- Editor-in-chief of CURE Magazine
Debu Tripathy, MD, is a professor of medicine and chair of the department of breast medical oncology at the University of Texas MD Anderson Cancer Center.
Dr. Tripathy’s clinical research focuses on evaluating and developing new treatments for breast cancer, specifically those targeting sensitivity and resistance mechanisms to growth factors, endocrine modulators, and cell cycle control pathways. He also investigates biomarkers predicting sensitivity and resistance. Dr. Tripathy has led clinical trials supporting the approval of new biological therapies for breast cancer targeting the HER2 oncogene and cyclin-dependent kinases, both improving patient survival.
Dr. Tripathy has published numerous original translational and landmark clinical research articles in the field of breast cancer. He serves on several editorial boards, study sections, and societies, and he is the editor-in-chief of CURE Magazine. He has previously served as president of the American Society of Breast Disease and the Society of Integrative Oncology.
Experience & accolades
Expertise
- Medical oncology
Education
- Duke University Medical Center
- Doctor of medicine
- Clinical internship
- University of California at San Francisco
- Clinical fellowship
- Massachusetts Institute of Technology
- Bachelor of science in chemical engineering
Experience
- MD Anderson Cancer Center (2014-Present)
- Professor
- Chair, department of breast medical oncology
- University of Southern California (2009-2014)
- Professor of medicine
- Physician’s Education Resource (2007-2009)
- President and CEO
- UT Southwestern Medical Center (2002-2007)
- Clinical professor of internal medicine
Publications
“EpCAM based capture detects and recovers circulating tumor cells from all subtypes of breast cancer except claudin-low,” Oncotarget, 2015
“Antitumor Activity of KW-2450 Against Triple-Negative Breast Cancer by Inhibiting Aurora A and B Kinases,” Molecular Cancer Therapy, 2015
“Modified Bi-Rads Scoring of Breast Imaging Findings Improves Clinical Judgment,” Breast Journal, 2015
“Validation and Development of a Modified Breast Graded Prognostic Assessment As a Tool for Survival in Patients With Breast Cancer and Brain Metastases,” Journal of Clinical Oncology, 2015
“The Neoadjuvant Model Is Still the Future for Drug Development in Breast Cancer,” Clinical Cancer Resources, 2015
